Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
156
NCT00616538
Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis
Phase: Phase 4
Role: Lead Sponsor
Start: Dec 31, 2006
Completion: Not specified
NCT00460083
Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis
Start: Apr 30, 2007
Completion: Feb 29, 2008